Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations

Urology

Volumn 45, Issue 3, 1995, Pages 387-397

  Messing, Edward M ^a,b   Young, Theresa B ^a   Hunt, Vernon B ^a   Gilchrist, Kennedy W ^a   Newton, Michael A ^a   Bram, Lora L ^a   Hisgen, William J ^a   Barry Greenberg, E ^a   Kuglitsch, Michael E ^a   Wegenke, John D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BLADDER NEOPLASMS; COMPARATIVE STUDY; FOLLOW-UP STUDIES; HEMATURIA; HUMAN; MALE; MIDDLE AGE; NEOPLASM STAGING; REAGENT STRIPS; SELF CARE; SUPPORT, NON-U.S. GOV'T;

EID: 0028802758     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80006-5     Document Type: Article

References (49)

1. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression
2. Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer
3. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group
4. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single Ta, T1 papillary carcinoma of the bladder
5. Early stage bladder cancer
6. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
7. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial
8. Hematuria screening for bladder cancer
9. Symposium on bladder tumors; current clinical problems regarding bladder tumors
10. Home screening for hematuria: results of a multiclinic study
11. Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age
12. Hematuria home screening: repeat testing 9 months after negative tests
13. Hematuria home screening: repeat testing 9 months after negative tests
14. Efficiently simulating coverage properties of interval estimates
15. The pathology of early urothelial cancer
16. Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension of metastases
17. Mode of presentation of invasive bladder cancer: reassessment of the problem
18. Invasive bladder cancer: support for screening
19. 1, grade 3 transitional cell carcinoma of the bladder
20. Two muscular pathways to transitional cell carcinoma of the bladder
21. The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, PI, PIS and P2)
22. Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder
23. Treatment options for patients with invasive bladder cancer with special reference to bladder substitution with the Stanford pouch
24. 1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy
25. Preoperative radiation therapy in the treatment of bladder cancer
26. Selective bladder preservation by combination treatment of invasive bladder cancer
27. o) transitional cell carcinoma of the bladder highly curable by radical cystectomy
28. Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study
29. Neoadjuvant cisplatin, methotrexate, and vinblastine for muscle-invasive bladder cancer: long-term followup
30. Are the known bladder cancer risk-factors associated with more advanced bladder cancer?
31. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder
32. Age as a predictor of an aggressive clinical course for superficial bladder cancer in men
33. Veterans administration's randomized benign prostatic hypertrophy study. Presented at the AUA Eighty-seventh annual meeting, May 12, 1992
34. A community study of bladder cancer screening by the detection of occult urinary bleeding
35. The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks
36. Dipstick hematuria and bladder cancer in men over 60: results of a community study
37. Symposium on bladder tumors: current clinical problems regarding bladder tumors
38. Epidemiology of renal and ureteral cancer in Rochester, Minnesota, 1950–1974, with special reference to clinical and pathologic features
39. Carcinoma of the bladder: a clinical and pathological analysis of 87 autopsy cases
40. Hematuria home screening: repeat testing results